Pain Control Adequate With Fewer Opioids After Corneal Surgery
After assessment of postoperative opioid use, patients receive fewer opioid tablets but pain is controlled
October 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for October 2019. This roundup includes the latest...
FDA Committee: Makena Should Be Removed From Market
Drug was approved by FDA in 2011 to reduce risk for preterm birth in at-risk women
Gilteritinib Superior in Relapsed, Refractory FLT3-Mutated AML
Overall survival significantly longer, percentage of remission higher than with salvage chemotherapy
Acute Kidney Injury Often Seen With Checkpoint Inhibitor Use
8 percent of patients receiving checkpoint inhibitor therapy experienced sustained acute kidney injury
Many Patients Take OTC Meds That May Interact With Apixaban
Less knowledge about OTC products with potentially serious interactions linked to increased use
CDC: U.S. Life Expectancy Up Slightly, Mortality Lower in 2017
Report shows decrease in age-adjusted death rates, increase in age-adjusted death rate from overdose
J&J Says No Asbestos Detected in New Tests of Baby Powder
Tests were performed by two third-party laboratories as part of the company's ongoing investigation
White House Launches Website to Help Those Battling Substance Abuse
FindTreatment.gov will allow Americans with substance abuse and mental health issues to better access care
Fetal Exposure to Acetaminophen May Increase Risk for ADHD, ASD
Cord biomarkers of in utero acetaminophen exposure tied to increased risk for childhood ADHD, ASD
